Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Diabetes, Obesity & Metabolism
|
June 28, 2023
First-in-human study of a pharmacological duodenal exclusion therapy shows reduced postprandial glucose and insulin and increased bile acid and gut hormone concentrations
Mark S Fineman, Christine L N Bryant, Kevin Colbert, et al.
BMJ Open
|
October 18, 2015
Telmisartan and Insulin Resistance in HIV (TAILoR): protocol for a dose-ranging phase II randomised open-labelled trial of telmisartan as a strategy for the reduction of insulin resistance in HIV-positive individuals on combination antiretroviral therapy
Sudeep P Pushpakom, Claire Taylor, Ruwanthi Kolamunnage-Dona, et al.
Diabetes, Obesity & Metabolism
|
July 2, 2021
What are the factors associated with long-term glycaemic control in patients with type 2 diabetes and elevated glycated haemoglobin (≥7.0%) at initiation of second-line therapy? Results from the DISCOVER study
Fabrice Bonnet, Hungta Chen, Andrew Cooper, et al.
Diabetes, Obesity & Metabolism
|
November 19, 2016
Cardiovascular events and all-cause mortality associated with sulphonylureas compared with other antihyperglycaemic drugs: A Bayesian meta-analysis of survival data
Steve Bain, Eric Druyts, Chakrapani Balijepalli, et al.
Diabetes Research and Clinical Practice
|
February 3, 2022
Quality of life in people with type 2 diabetes in the 3 years following initiation of second-line therapy: The DISCOVER study
Antonio Nicolucci, Hungta Chen, Andrew Cooper, et al.
Diabetes, Obesity & Metabolism
|
September 16, 2022
Treatment patterns and glycated haemoglobin levels over 36 months in individuals with type 2 diabetes initiating second-line glucose-lowering therapy: The global DISCOVER study
Bernard H Charbonnel, Hungta Chen, Javier Cid-Ruzafa, et al.
Plos One
|
September 27, 2013
The association of a panel of biomarkers with the presence and severity of carcinoid heart disease: a cross-sectional study
Rebecca Dobson, Malcolm I Burgess, Melissa Banks, et al.
Indian Heart Journal
|
August 4, 2022
Association of country economy and socioeconomic factors on risk factor control for primary prevention of cardiovascular disease in patients with diabetes mellitus: Insights from the DISCOVER study
Ali O Malik, Hungta Chen, Fengming Tang, et al.
Diabetes, Obesity & Metabolism
|
May 13, 2022
Factors associated with weight loss in people with overweight or obesity living with type 2 diabetes mellitus: Insights from the global DISCOVER study
Vittal Hejjaji, Juan J Gorgojo-Martinez, Fengming Tang, et al.
American Heart Journal
|
October 19, 2021
Incidence rates and predictors of microvascular and macrovascular complications in patients with type 2 diabetes: Results from the longitudinal global discover study
Suzanne V Arnold, Kamlesh Khunti, Fengming Tang, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Diabetes, Obesity & Metabolism
|
June 28, 2023
First-in-human study of a pharmacological duodenal exclusion therapy shows reduced postprandial glucose and insulin and increased bile acid and gut hormone concentrations
Mark S Fineman, Christine L N Bryant, Kevin Colbert, et al.
BMJ Open
|
October 18, 2015
Telmisartan and Insulin Resistance in HIV (TAILoR): protocol for a dose-ranging phase II randomised open-labelled trial of telmisartan as a strategy for the reduction of insulin resistance in HIV-positive individuals on combination antiretroviral therapy
Sudeep P Pushpakom, Claire Taylor, Ruwanthi Kolamunnage-Dona, et al.
Diabetes, Obesity & Metabolism
|
July 2, 2021
What are the factors associated with long-term glycaemic control in patients with type 2 diabetes and elevated glycated haemoglobin (≥7.0%) at initiation of second-line therapy? Results from the DISCOVER study
Fabrice Bonnet, Hungta Chen, Andrew Cooper, et al.
Diabetes, Obesity & Metabolism
|
November 19, 2016
Cardiovascular events and all-cause mortality associated with sulphonylureas compared with other antihyperglycaemic drugs: A Bayesian meta-analysis of survival data
Steve Bain, Eric Druyts, Chakrapani Balijepalli, et al.
Diabetes Research and Clinical Practice
|
February 3, 2022
Quality of life in people with type 2 diabetes in the 3 years following initiation of second-line therapy: The DISCOVER study
Antonio Nicolucci, Hungta Chen, Andrew Cooper, et al.
Diabetes, Obesity & Metabolism
|
September 16, 2022
Treatment patterns and glycated haemoglobin levels over 36 months in individuals with type 2 diabetes initiating second-line glucose-lowering therapy: The global DISCOVER study
Bernard H Charbonnel, Hungta Chen, Javier Cid-Ruzafa, et al.
Plos One
|
September 27, 2013
The association of a panel of biomarkers with the presence and severity of carcinoid heart disease: a cross-sectional study
Rebecca Dobson, Malcolm I Burgess, Melissa Banks, et al.
Indian Heart Journal
|
August 4, 2022
Association of country economy and socioeconomic factors on risk factor control for primary prevention of cardiovascular disease in patients with diabetes mellitus: Insights from the DISCOVER study
Ali O Malik, Hungta Chen, Fengming Tang, et al.
Diabetes, Obesity & Metabolism
|
May 13, 2022
Factors associated with weight loss in people with overweight or obesity living with type 2 diabetes mellitus: Insights from the global DISCOVER study
Vittal Hejjaji, Juan J Gorgojo-Martinez, Fengming Tang, et al.
American Heart Journal
|
October 19, 2021
Incidence rates and predictors of microvascular and macrovascular complications in patients with type 2 diabetes: Results from the longitudinal global discover study
Suzanne V Arnold, Kamlesh Khunti, Fengming Tang, et al.
Page
of 5